Skip Header

15 results for author:"Tennent G.A." in Literature citations

Page 1 of 1

to top of page·  

Results Customize

› Repeat search in UniProtKB (4)

Isolation and characterization of pharmaceutical grade human pentraxins, serum amyloid P component and C-reactive protein, for clinical use.

Pepys M.B., Gallimore J.R., Lloyd J., Li Z., Graham D., Taylor G.W., Ellmerich S., Mangione P.P., Tennent G.A., Hutchinson W.L. et al.

J. Immunol. Methods 384:92-102(2012) · Mapped (3)

Trapping of palindromic ligands within native transthyretin prevents amyloid formation.

Kolstoe S.E., Mangione P.P., Bellotti V., Taylor G.W., Tennent G.A., Deroo S., Morrison A.J., Cobb A.J., Coyne A., McCammon M.G. et al.

Proc. Natl. Acad. Sci. U.S.A. 107:20483-20488(2010) · Mapped (1)

A common beta-sheet architecture underlies in vitro and in vivo beta2-microglobulin amyloid fibrils.

Jahn T.R., Tennent G.A., Radford S.E.

J. Biol. Chem. 283:17279-17286(2008) · Mapped (17)

Transgenic human CRP is not pro-atherogenic, pro-atherothrombotic or pro-inflammatory in apoE-/- mice.

Tennent G.A., Hutchinson W.L., Kahan M.C., Hirschfield G.M., Gallimore J.R., Lewin J., Sabin C.A., Dhillon A.P., Pepys M.B.

Atherosclerosis 196:248-255(2008) · Mapped (2)

Normal circulating serum amyloid P component concentration in systemic sclerosis.

Tennent G.A., Dziadzio M., Triantafillidou E., Davies P., Gallimore J.R., Denton C.P., Pepys M.B.

Arthritis Rheum. 56:2013-2017(2007) · Mapped (1)

Beta-edge interactions in a pentadecameric human antibody V kappa domain.

James L.C., Jones P.C., McCoy A., Tennent G.A., Pepys M.B., Famm K., Winter G.

J. Mol. Biol. 367:603-608(2007) · UniProtKB (1)

A systematic study of the effect of physiological factors on beta2-microglobulin amyloid formation at neutral pH.

Myers S.L., Jones S., Jahn T.R., Morten I.J., Tennent G.A., Hewitt E.W., Radford S.E.

Biochemistry 45:2311-2321(2006) · Mapped (7)

Proinflammatory effects of bacterial recombinant human C-reactive protein are caused by contamination with bacterial products, not by C-reactive protein itself.

Pepys M.B., Hawkins P.N., Kahan M.C., Tennent G.A., Gallimore J.R., Graham D., Sabin C.A., Zychlinsky A., de Diego J.

Circ. Res. 97:e97-103(2005) · Mapped (17)

Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice.

Hirschfield G.M., Gallimore J.R., Kahan M.C., Hutchinson W.L., Sabin C.A., Benson G.M., Dhillon A.P., Tennent G.A., Pepys M.B.

Proc. Natl. Acad. Sci. U.S.A. 102:8309-8314(2005) · Mapped (15)

Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis.

Pepys M.B., Herbert J., Hutchinson W.L., Tennent G.A., Lachmann H.J., Gallimore J.R., Lovat L.B., Bartfai T., Alanine A., Hertel C. et al.

Nature 417:254-259(2002) · Mapped (5)

Transthyretin Ile73Val is associated with familial amyloidotic polyneuropathy in a Bangladeshi family.

Booth D.R., Gillmore J.D., Persey M.R., Booth S.E., Cafferty K.D., Tennent G.A., Madhoo S., Cochrane S.W., Whitehead T.C., Pasvol G. et al.

Hum. Mutat. 12:135-135(1998) · UniProtKB (1)

Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity.

Bickerstaff M.C., Botto M., Hutchinson W.L., Herbert J., Tennent G.A., Bybee A., Mitchell D.A., Cook H.T., Butler P.J., Walport M.J. et al.

Nat. Med. 5:694-697(1999) · Mapped (2)

Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene.

Botto M., Hawkins P.N., Bickerstaff M.C., Herbert J., Bygrave A.E., McBride A., Hutchinson W.L., Tennent G.A., Walport M.J., Pepys M.B.

Nat. Med. 3:855-859(1997) · Mapped (2)

Human lysozyme gene mutations cause hereditary systemic amyloidosis.

Pepy M.B., Hawkins P.N., Booth D.R., Vigushin D.M., Tennent G.A., Soutar A.K., Totty N., Nguyen O., Blake C.C.F., Terry C.J. et al.

Nature 362:553-557(1993) · UniProtKB (1) · Mapped (4)

Apolipoprotein AI mutation Arg-60 causes autosomal dominant amyloidosis.

Soutar A.K., Hawkins P.N., Vigushin D.M., Tennent G.A., Booth S.E., Hutton T., Nguyen O., Totty N.F., Feest T.G., Hsuan J.J. et al.

Proc. Natl. Acad. Sci. U.S.A. 89:7389-7393(1992) · UniProtKB (1)

to top of page·

Page 1 of 1